A Study on Neoadjuvant Therapy for Her-2 Positive Breast Cancer and the Prognosis by Detecting CTCs
Status: UNKNOWN
Study type: INTERVENTIONAL
Conditions: Breast Neoplasms
Interventions: DRUG: Epirubicin|DRUG: Docetaxel|DRUG: Trastuzumab|DRUG: Carboplatin
Sponsor: Hospital Affiliated to Military Medical Science, Beijing